Search Results
Oct 28, 2025, 06:55 ET Invesco Reports Results for the Three Months Ended September 30, 2025
Q3-25 vs. Q2-25
More news about: Invesco Ltd.
Oct 28, 2025, 06:45 ET PayPal Launches Agentic Commerce Services to Power AI-Driven Shopping
product discovery and conversion: Merchants can benefit from discovery within AI shopping surfaces and drive conversions with intent-driven shopping vs. traditional search, browse, and cart experiences. Preserve customer insights and
More news about: PayPal Holdings, Inc.
Oct 28, 2025, 06:32 ET ROYAL CARIBBEAN GROUP REPORTS THIRD QUARTER RESULTS, INCREASES FULL YEAR GUIDANCE AND ANNOUNCES A NEW EXCLUSIVE DESTINATION
Net Yields vs. 2024
More news about: Royal Caribbean Group
Oct 27, 2025, 23:15 ET 호텔스닷컴, 한국 여행시장 변화와 2026년 여행 트렌드 담은 '언팩 '26' 공개
가능하다.2 호텔스닷컴 — 2026 올해의 호텔: 역사를 품은 스테이 본 데이터는 호텔스닷컴 전 세계 호텔 검색량의 연도별 증가율을 기반으로 분석했다. (비교 기간: 2024년 1월 1일~12월 31일 vs. 2025년 1월 1일~12월 31일) 3 호텔스닷컴 — 호텔 호핑 본 데이터는 호텔스닷컴의 전 세계 '호텔+호텔' 연계 예약 수요 증가율을 기반으로 분석했다. (데이터 기간: 2024년 1월 1일~12월
More news about: Expedia
Oct 27, 2025, 19:59 ET GRUPO SIMEC ANNOUNCES RESULTS OF OPERATIONS FOR THE FIRST NINE MONTHS OF 2025
of operations for the nine-month period ended September 30, 2025. Comparative first nine months of 2025 vs. first nine months of 2024 Net Sales
More news about: Grupo Simec, S.A.B. de C.V.
Oct 27, 2025, 16:58 ET Ar-Condicionado LG transforma Home Office com foco em produtividade
reorganizou suas operações em quatro divisões de negócios:Home Appliance Solution (HS), Media Entertainment Solution (MS), Vehicle Solution (VS) e Eco Solution (ES), redefinindo seus papéis e identidades para acelerar sua visão de futuro até 2030. Em 2024, as quatro divisões combinadas
More news about: LG Electronics Brasil
Oct 27, 2025, 16:45 ET LG Brasil revoluciona a experiência gamer com tecnologia AI Gaming
reorganizou suas operações em quatro divisões de negócios: Home Appliance Solution (HS), Media Entertainment Solution (MS), Vehicle Solution (VS) e Eco Solution (ES), redefinindo seus papéis e identidades para acelerar sua visão de futuro até 2030. Em 2024, as quatro divisões combinadas
More news about: LG Electronics Brasil
Oct 27, 2025, 16:15 ET RAMACO RESOURCES REPORTS THIRD QUARTER 2025 RESULTS
Berwind Complex, full-year 2025 production is now anticipated to come in at 3.7 – 3.9 million tons vs. 3.9 million tons previously. Full-year 2025 sales are now anticipated to come in at 3.8 – 4.1 million tons vs. 4.1 million tons previously.
More news about: Ramaco Resources, Inc.
Oct 27, 2025, 16:10 ET Leggett & Platt Reports 3Q 2025 Results
sales of $1.0 billion, a 6% decrease vs 3Q24 3Q EPS of $0.91, 3Q adjusted1 EPS of $0.29, a $0.03 decrease vs adjusted1 3Q24 EPS 3Q operating cash flow of $126 million, a $30 million increase vs 3Q24 Strengthened
More news about: Leggett & Platt Incorporated
Oct 27, 2025, 16:05 ET Northwest Bancshares, Inc. Announces Third Quarter 2025 GAAP net income of $3 million, or $0.02 per diluted share
Change 3Q25 vs.
More news about: Northwest Bancshares, Inc.
Oct 27, 2025, 15:13 ET Domain Name System (DNS) Firewall Market to Reach USD 5.51 billion by 2032, Growing At An 15% CAGR - Credence Research
In September 2025, Cloudflare launched DNS Firewall Analytics, enabling customers to access 62 days of DNS query history, visualize cached vs. uncached traffic, and analyze data-center-level performance. In June 2025, Akamai Technologies introduced DNS Posture Management,
More news about: Credence Research Inc.
Oct 27, 2025, 10:48 ET Friendsgiving All Season: Buy an Epic Pass Now and Your Friends Will Be Thankful with New Epic Friend Tickets
Epic 1–7 Day Passes save up to 65% vs. lift tickets, starting at $50–$106 (Epic Friend Tickets not included). The One Where
More news about: Vail Resorts
Oct 27, 2025, 10:01 ET Protein Ingredients Market to Reach USD 125.1 Billion by 2031 Amid Rising Demand for Functional Nutrition and Sustainable Protein Sources | DataM Intelligence
Market Segmentation Analysis By Product: Plant Proteins vs. Animal Proteins The protein ingredients market is broadly segmented into plant proteins and animal
More news about: DataM Intelligence 4 Market Research LLP
Oct 27, 2025, 09:00 ET Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
(RV/LV) diameter ratio within 48 hours (mean reduction 0.52 vs. 0.24; P<0.001) and nearly 80% of patients had positive treatment effect with CAVT which was significantly greater than the patients who received anticoagulation alone (78.3% vs. 51.9%; P =0.011), reflecting rapid hemodynamic recovery.
More news about: Penumbra, Inc.
Oct 27, 2025, 08:30 ET AI's Growth Has a Power Problem -- Natural Hydrogen Could Be the Perfect Solution
commerciality, a potential major breakthrough in clean, baseload energy. To appreciate why that matters, contrast manufactured vs. natural hydrogen. Today about 99% of hydrogen is produced either via steam-methane
More news about: NetworkNewsWire
Oct 27, 2025, 08:00 ET Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update
has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized (designed as non-inferiority vs vancomycin), primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. With mutually consistent
More news about: Acurx Pharmaceuticals, Inc.
Oct 27, 2025, 08:00 ET New Oshi Health Research at ACG 2025 Demonstrates Improved Outcomes and Cost Savings At Scale Through Virtual, Multidisciplinary GI Care
reached 100%. For patients with liver disease, the average time to the first specialist appointment decreased to six days (vs a 71-day national average), with symptom severity and satisfaction improving significantly following care.
More news about: Oshi Health
Oct 27, 2025, 06:27 ET Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species
provide leading-edge protection for dogs against a complex and evolving parasitic landscape." Lotilaner vs. Lyme Disease The active ingredient lotilaner in both Credelio Quattro and Credelio has been found highly effective for
More news about: Elanco Animal Health
Oct 27, 2025, 06:15 ET Keurig Dr Pepper Reports Q3 2025 Results, Raises Full Year Net Sales Outlook and Reaffirms EPS Guidance for 2025
% vs prior year
More news about: Keurig Dr Pepper
Oct 26, 2025, 20:00 ET Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
semaglutide on the primary endpoint—the proportion of participants achieving HbA1c < 7.0% and ≥10% body weight reduction from baseline at week 32 (48.0 vs. 21.0%, p<0.0001). In addition, at week 32, the mean change in HbA1c from baseline was −2.03% in the mazdutide group and −1.84% in semaglutide group,
More news about: Innovent Biologics
Oct 26, 2025, 17:24 ET Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
24-hour ABPM: −14.0 mmHg in the RDN group vs. −9.3 mmHg in the sham group (treatment difference: −4.7 mmHg; p=0.0028) OSBP: −18.5 mmHg in the RDN group vs. −11.7 mmHg in the sham group (treatment difference: −7.4 mmHg; p=0.0002)
More news about: Medtronic plc
Oct 26, 2025, 15:00 ET Cordis Unveiled Breakthrough Results from SELUTION DeNovo and SELUTION4ISR Randomized Trials at TCT 2025, Transforming Coronary Artery Disease (CAD) Treatment Beyond Stenting
demonstrated non-inferior performance against ISR standard-of-care treatment. Target lesion failure (TLF) at 12-months was 15.2% with SELUTION SLR™ DEB vs. 13.5% in standard of care control which was comprised of 80% DES. These results will be leveraged to support a submission to FDA for coronary ISR indication
More news about: Cordis
Oct 24, 2025, 18:32 ET Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies
increase from baseline) was observed in more than twice as many patients in the high dose nipocalimab group (15 mg/kg) compared to the placebo group (33% vs. 16%, respectively) at Week 24.1 "The DAHLIAS Phase 2 study represents an important step forward in the understanding
More news about: Johnson & Johnson
Oct 24, 2025, 13:24 ET CA Oversight Report Shows Decade of Gasoline Price Gouging, says Consumer Watchdog
report also found refining margins at branded gasoline stations were much greater than at unbranded stations over the last decade – 75 cents per gallon vs 41 cents per gallon. This shows vertically integrated refiners, such as Chevron and Marathon, have used their market power to jack up rates at branded
More news about: Consumer Watchdog
Oct 24, 2025, 10:33 ET KuCoin Brings Fresh Brand, Trust-Driven Innovation, and Mining Vision to Dubai's Blockchain Life 2025
sustainability, and user empowerment. KuCoin's thought leadership continues with Managing Director Alicia Kao joining the panel "DEX vs. CEX: Evolution of Exchange and New Competition" on October 28, alongside other top industry leaders, to explore the future of trading and exchange
More news about: KuCoin